Sickle Cell Trait Whole Blood
Fresh whole blood from IRB-consented donors with a confirmed HbAS genotype. Sickle cell trait is a heterozygous carrier state, not sickle cell disease, and carriers are generally asymptomatic. Useful for HBB genotyping, haemoglobin electrophoresis and HPLC method development, carrier screening assay validation, population genetics and normal-range comparator cohorts.
Sickle Cell Trait Whole Blood for Population Genetics and Haematology Research
Sickle Cell Trait Whole Blood is collected from IRB-consented donors with a confirmed HbAS genotype and shipped same day. Sickle cell trait is a heterozygous carrier state: the donor carries one normal beta-globin allele and one HBB sickle allele, and therefore produces both HbA and HbS. It is a carrier state, not sickle cell disease. Individuals with sickle cell trait are generally healthy and largely asymptomatic, and our donors are consented as carriers rather than as patients. These fresh samples support population genetics, screening assay development and comparator-cohort research.
Carrier Genetics, HbS/HbA Ratio and Why Whole Blood
- Sickle cell trait is defined by heterozygosity for the HBB sickle variant. One functional beta-globin allele is retained, so haemoglobin polymerisation does not occur under ordinary physiological conditions and red cell lifespan is essentially preserved.
- On haemoglobin electrophoresis or HPLC, carriers show both HbA and HbS, with HbA the predominant fraction. This characteristic two-peak pattern is what distinguishes trait from homozygous disease and is the basis of confirmatory testing.
- Distinguishing HbAS from HbSS and from compound heterozygous states is precisely the analytical challenge that carrier screening and newborn screening assays must solve, which makes genotype-confirmed trait material valuable reference material.
- The high carrier frequency in populations with historical malaria exposure is one of the best-documented examples of balancing selection in humans, and HbAS red cells remain a widely used system in malaria-resistance research.
- Carrier status is relevant to reproductive genetic counselling, since two carriers may have a child with sickle cell disease — supporting demand for robust, well-characterised carrier detection assays.
- Whole blood supplies genomic DNA for HBB genotyping, intact red cells for electrophoresis, HPLC and isoelectric focusing, and the plasma compartment, all from a single collection.
Donor Stratification Available
- Confirmation method: haemoglobin electrophoresis, HPLC, or molecular HBB genotyping
- Documented HbS and HbA fraction where available
- Self-reported ancestry and geographic origin for population genetics cohorts
- Co-inherited haemoglobin or red cell traits where documented, such as alpha-thalassaemia trait or G6PD deficiency
- Age and sex assigned at birth for demographically balanced cohort assembly
- Matched healthy controls available, including HbAA donors for assay comparison, and sickle cell disease donors where a disease comparator is required
Product Features
- Fresh whole blood from donors with confirmed sickle cell trait
- Custom anticoagulants and collection tubes available
- Same-day collection and shipment
- Custom volumes available on request
- Research Use Only (RUO)
De-identified Donor Data
- Confirmed HbAS genotype by haemoglobin electrophoresis or genetic testing
- Demographics: age, sex assigned at birth, ethnicity
- Relevant medical and family history
- Confirmation method and documented haemoglobin fractions where available
Applications
- HBB gene variant detection and genotyping assay development
- Haemoglobin electrophoresis, HPLC and isoelectric focusing method development
- Carrier screening and newborn screening assay validation
- Reference and control material for haemoglobinopathy diagnostic panels
- Population genetics and allele frequency studies
- Malaria resistance and host genetic protection research
- Normal-range comparator cohort for sickle cell disease studies
- Gene expression and transcriptomic analysis in a heterozygous background
- Red cell biology and exercise physiology research in carriers
Other Sickle Cell Trait Specimen Types
- Sickle Cell Trait Plasma
- Sickle Cell Trait Bulk Plasma
- Sickle Cell Trait Serum
- Sickle Cell Trait PBMC
- Sickle Cell Trait Leukopak
Looking for sickle cell disease specifically, rather than the carrier state? See our Sickle Cell Disease Whole Blood product.
Compliance and Quality Assurance
- IRB-approved protocols and electronic informed consent
- HIPAA-compliant donor data handling
Ordering & Customization
Sickle cell trait whole blood is available in standard and custom volumes. For pricing, current availability, international orders or documentation requirements, email learnmore@sanguinebio.com. To browse donor cohorts across our full inventory, visit our human whole blood page.
Whole Blood
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Whole Blood cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.